Fidia worldwide

Fidia Pharma USA Inc is a wholly-owned subsidiary of Italian pharmaceutical manufacturer Fidia Farmaceutici S.p.A., focused on continually expanding Fidia's position in the U.S. market, while upholding the company's mission to provide consumers with innovative products that offer quality, safety and performance.

Drawing on the strengths of the parent company, Fidia Pharma USA product portfolio focuses primarily on therapeutic areas such as musculoskeletal, rheumatology, and women's health.

Learn more about the Company, visit www.fidiapharma.us

Fidia Pharma Kazakhstan LLC is focused on expanding Fidia's position in the most accessible pharmaceutical market in Central Asia, consistently with the Company's mission and strategy pillars.

Drawing on the strengths of the parent company, Fidia Pharma Kazakhstan product portfolio focuses primarily on therapeutic areas such as joint healthcare, tissue repair and dermatology, as well as CNS pathologies.

Fourth in the Group, in addition to Italian headquarters and the US and Kazak subsidiaries, Fidia Pharma GmbH represents an additional step in the company's internationalization plan, a higher penetration of Fidia's products in the European market and a more direct, stronger contribution to the spreading and widening of Italian research and industrial excellence worldwide

Fidia Pharma GmbH will initially focus on the viscosupplementation for synovial joints and wound care areas, through products containing hyaluronic acid.

Learn more about the Company, visit www.fidiapharma.de